Is Very High Thyroid Stimulating Hormone Level Required in Differentiated Thyroid Cancer for Ablation Success? | Zendy

Zekiye Hasbek | Zendy; Bülent Turgut | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Is Very High Thyroid Stimulating Hormone Level Required in Differentiated Thyroid Cancer for Ablation Success?

Author(s) -

Zekiye Hasbek,

Bülent Turgut

Publication year - 2016

Publication title -

molecular imaging and radionuclide therapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.292

H-Index - 7

eISSN - 2147-1959

pISSN - 2146-1414

DOI - 10.4274/mirt.88598

Subject(s) - medicine , ablation , thyroid , hormone , thyroid cancer , thyroidectomy , thyroglobulin , thyroid stimulating hormone , metastasis , cancer , radioactive iodine , urology , gastroenterology , endocrinology , nuclear medicine

Remnant ablation with radioactive iodine (I-131) is a successful form of treatment that aims to destroy the remaining residual tissue and/or metastatic tissue after total thyroidectomy in differentiated thyroid cancer (DTC) patients. High level of thyroid stimulating hormone (TSH) (≥30 mIU/L) is recommended for success of ablation treatment. In this retrospective study, our aim was to investigate whether the TSH levels at the time of ablation effect the success of radioactive iodine remnant ablation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research